GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study

医学 内科学 胃肠病学 溃疡性结肠炎 回顾性队列研究 优势比 队列 队列研究 逻辑回归 兴奋剂 炎症性肠病 利拉鲁肽 减肥 维多利祖马布 疾病严重程度 前瞻性队列研究 倾向得分匹配 不利影响 外科 克罗恩病 胰高血糖素样肽1受体 自发缓解 疾病
作者
Budoor Alqinai,Swapna Gayam,Jennifer Hadam-Veverka
出处
期刊:Inflammatory Bowel Diseases [Oxford University Press]
被引量:4
标识
DOI:10.1093/ibd/izag167
摘要

BACKGROUND: Ulcerative colitis (UC) remains associated with significant morbidity despite therapeutic advances. The impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on UC disease activity is not well defined. METHODS: We performed a retrospective cohort study using electronic health records from a single tertiary academic health system (2022-2024). Adults with UC initiating liraglutide or semaglutide for metabolic indications and maintained on therapy ≥ 12 weeks were included. A 1:1 matched cohort of UC patients not receiving GLP-1 RAs served as controls. The primary outcome was symptomatic remission at 12 weeks (partial Mayo ≤ 2 with rectal bleeding subscore 0). Multivariable logistic regression assessed adjusted odds of remission. RESULTS: A total of 150 GLP-1 RA patients were matched to 150 controls with comparable baseline characteristics. GLP-1 RA use was associated with higher remission rates at 4 weeks (34.7% vs 15.3%, P = .001), 8 weeks (54.7% vs 18.0%, P < .001), and 12 weeks (66.7% vs 25.3%, P < .001). Mean partial Mayo scores improved from 5.8 at baseline to 2.1 at 12 weeks in the GLP-1 RA group vs 4.6 in controls (P < .01). GLP-1 RA use remained independently associated with remission (adjusted OR 5.90, 95% CI 3.52-9.86; P < .001). Weight loss was not associated with remission. Semaglutide demonstrated higher remission rates than liraglutide (72.5% vs 60%; OR 1.77, P = .04). Endoscopic outcomes in a subset showed higher remission (58% vs 38%) and improvement (69% vs 47%). CONCLUSION: GLP-1 RA therapy was associated with significantly improved UC disease activity and higher remission rates compared to matched controls, with a modest advantage observed for semaglutide. These findings support a potential adjunctive role for GLP-1 RAs in UC, particularly in patients with metabolic comorbidities.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
帅帅完成签到,获得积分10
刚刚
刚刚
好困的应助被HAi采纳,获得10
刚刚
fantasy的应助被不过尔尔采纳,获得10
刚刚
传奇3的应助被愉快幻天采纳,获得10
1秒前
害羞的凝竹完成签到 ,获得积分10
1秒前
2秒前
HUANGCHUN发布了新的文献求助30
2秒前
2秒前
3秒前
3秒前
CarryLJR发布了新的文献求助10
3秒前
3秒前
3秒前
3秒前
AHR发布了新的文献求助30
4秒前
4秒前
WYL发布了新的文献求助10
5秒前
WYL发布了新的文献求助10
5秒前
WYL发布了新的文献求助10
5秒前
Jennie发布了新的文献求助10
5秒前
WYL发布了新的文献求助10
5秒前
Owen的应助被111采纳,获得10
5秒前
耳朵在安上完成签到 ,获得积分10
6秒前
搜集达人的应助被Suichan采纳,获得10
6秒前
烂漫芷雪完成签到,获得积分10
6秒前
嘻嘻嘻发布了新的文献求助10
6秒前
6秒前
7秒前
8秒前
8秒前
8秒前
WYL发布了新的文献求助10
8秒前
8秒前
8秒前
哈呼呼发布了新的文献求助10
8秒前
WYL发布了新的文献求助10
8秒前
8秒前
猪宝芊完成签到,获得积分20
8秒前
WYL发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417